Kaufman R L, Oger J
Department of Pathology, University of British Columbia, Vancouver, Canada.
J Neuroimmunol. 1989 Jun;23(1):83-7. doi: 10.1016/0165-5728(89)90076-3.
To investigate whether nicotinic acetylcholine receptors might be present on blood mononuclear cells we studied the binding [125I]alpha-bungarotoxin to mononuclear cells from three normal controls and seven myasthenia gravis patients. The medulloblastoma cell line, TE671, which expresses a functional nicotinic acetylcholine receptor having pharmacological properties similar to that of skeletal muscle receptor, was used as a positive control for alpha-bungarotoxin binding. None of the mononuclear cell samples studied exhibited specific binding of alpha-bungarotoxin.